PD1 ANTIBODY
Clinical trials for PD1 ANTIBODY explained in plain language.
Never miss a new study
Get alerted when new PD1 ANTIBODY trials appear
Sign up with your email to follow new studies for PD1 ANTIBODY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to stop bile duct cancer from coming back
Disease control OngoingThis study tests whether giving a combination of immunotherapy (Toripalimab), a targeted drug (Lenvatinib), and chemotherapy (GEMOX) before surgery can improve outcomes for people with a high-risk type of bile duct cancer. About 178 participants will be randomly assigned to recei…
Matched conditions: PD1 ANTIBODY
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Can scans decide who needs surgery after liver tumor shrinks?
Knowledge-focused OngoingThis study looks back at 500 people with liver cancer that was too large to remove at first. After a mix of treatments (TACE, lenvatinib, and an immunotherapy drug), their tumors shrank enough to consider surgery. Researchers will use scans and medical records to see if certain p…
Matched conditions: PD1 ANTIBODY
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated May 26, 2026 07:25 UTC